Official Title
Moxibustion Plus Cupping in Convalescent Patients With COVID-19: A Randomized Clinical Trial
Brief Summary

This trial is designed to evaluate the efficacy and safety of moxibustion plus cupping in the convalescence of COVID-19.

Detailed Description

Moxibustion plus cupping may be effective and safe for convalescent patients with COVID-19,
but evidence is limited. The randomized clinical trial may help to provide evidence-based
factors for improving the patients' symptoms in the convalescence of COVID-19.

Recruiting
COVID-19
Convalescence

Other: Moxibustion plus Cupping

Moxibustion: The burning of a small, thimble sized, smoldering plug of dried leaves on the skin at an acupuncture point. Usually the plugs contain leaves of mugwort or moxa. Cupping takes the pot as a tool, uses the combustion to remove the air in the pot, causes a negative pressure, and makes it adsorb on the skin of the acupoints. Use"Baixiaojiu"moxibustion on each acupoint for 10-15 minutes, the temperature of moxibustion should be adjusted within patient's tolerance level. Use diameter of 5-6 cm acuum cupper to cupping on each acupoint for 5-8 minutes.

Eligibility Criteria

Inclusion Criteria:

1. Clinical diagnosis of the convalescence of COVID-19 (defined by the Chinese Guideline
for COVID-19 in 2020 Trial Version 7).

2. 18-70 years old;

3. chest tightness/fatigue/shortness of breath/cough, with at least 2 of the above
symptoms and the average VAS score (last 48 hours) ≥ 40 points;

4. Volunteers with informed consent;

Exclusion Criteria:

1. Surgery in the lung that affects lung function;

2. Rely on mechanical ventilation to maintain lung function;

3. Chronic lung diseases affecting lung function;

4. Diseases affecting heart function;

5. Severe basic diseases;

6. Resting heart rate > 120/min, systolic blood pressure > 180mmHg, diastolic blood
pressure > 100mmHg;

7. Unstable angina or myocardial infarction in the past 1 month;

8. Severe obesity (BMI>30kg/m2);

9. Allergic constitution;

10. Pregnant or lactating women;

11. Disabled patients;

12. Mentally ill Patients;

13. Participating in other clinical trials;

14. Poor compliance or other complicate conditions according to the researchers.

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: 70 Years
Countries
China
Locations

Hubei Province Hospital
Wuhan, Hubei, China

Investigator: Zhongyu Zhou
Contact: +86 18672308659
2209447940@qq.com

Contacts

Jiani Wu
+86 13426116653
handsom_mars@126.com

Guang'anmen Hospital of China Academy of Chinese Medical Sciences
NCT Number
Keywords
Moxibustion
Covid-19
Randomized Clinical Trial
MeSH Terms
COVID-19
Convalescence